49. Systemic lupus erythematosus Clinical trials / Disease details
Clinical trials : 946 / Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02066311 (ClinicalTrials.gov) | September 2014 | 12/2/2014 | Nelfinavir in Systemic Lupus Erythematosus | Nelfinavir in Systemic Lupus Erythematosus: A Pilot Phase IIa Clinical Trial | Systemic Lupus Erythematosus | Drug: Nelfinavir | Northwell Health | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Terminated | 18 Years | 65 Years | All | 15 | Phase 2 | United States |